Evommune, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
36.3M
on 2026-06-30, from 1.55M on 2025-09-30 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
10.8 quarters
$200.8M on 2026-06-30 ÷ $18.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-02-12 | Private placement | 4,494,279 | not read | $125.0M | 8-K ↗ |
| 2025-11-06 | Public offering | 9,375,000 | $16.00 | not read | 424B4 ↗ |